Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
Laura Poupon(Inserm), Jérôme Busserolles(Inserm), Laëtitia Prival(Inserm), Mathieu Méleine(Inserm), David Balayssac(Inserm), David André Barrière(Université de Tours), Sylvain Lamoine(Inserm), Nicolas Kerckhove(Centre Hospitalier Universitaire de Clermont-Ferrand), Michel Lazdunski(Centre National de la Recherche Scientifique), Stéphane Lolignier(Inserm), Alain Eschalier(Université Clermont Auvergne), Fabrice Giraudet(Centre National de la Recherche Scientifique), Nicolas Authier(Inserm), Vanessa Pereira(Inserm), Damien Richard(Inserm), Youssef Aissouni(Inserm)
Cited by 70
Related Papers
The regulation of the intracellular pH in cells from vertebrates
|European Journal of Biochemistry|1988|308
Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism
|Clinical Pharmacology & Therapeutics|2006|278
Hypervulnerability to Sound Exposure through Impaired Adaptive Proliferation of Peroxisomes
|Cell|2015|218
Acetaminophen Reinforces Descending Inhibitory Pain Pathways
|Clinical Pharmacology & Therapeutics|2007|173